Patents by Inventor Fernando Couto

Fernando Couto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124657
    Abstract: The present invention relates to a method for optimization and recovery of second-generation sugar diluted stream, comprising pretreatment, enzymatic hydrolysis and mainly washing the residual solid from the enzymatic hydrolysis, which allows the increase of sugar recovery. The use of this sugar diluted stream is crucial for process integration, may have different possibilities of use, for example, can be applied in the mechanical refining step, microorganisms propagation, enzyme production, fermentation, enzymatic hydrolysis, including combination of uses.
    Type: Application
    Filed: October 13, 2023
    Publication date: April 18, 2024
    Inventors: Luiz Fernando MARTINS BANDEIRA, Viviane MARCOS NASCIMENTO VICENTE, Carlos Eduardo DRIEMEIER, Christian ALEJANDRO QUEIPO, Danuza NOGUEIRA MOYSES, Absai DA CONCEIÇAO GOMES, Isabelle LOBO DE MESQUITA SAMPAIO, Ana Paula RODRIGUES TORRES, Felipe DE OLIVEIRA BRITO, Adriano DO COUTO FRAGA, Tassia LOPES JUNQUEIRA, Aline MACHADO DE CASTRO
  • Publication number: 20060216293
    Abstract: The invention provides monoclonal antibodies that neutralize TN? activity. The monoclonal antibodies may be rabbit monoclonal antibodies or monoclonal antibodies having CDR regions derived from those rabbit monoclonal antibodies. In certain embodiments, the monoclonal antibodies may be humanized. Methods of using the subject antibodies to inhibit TNF? activity, methods of treatment using those antibodies and kits containing the same are also provided. The invention finds use in a variety of research and medical applications.
    Type: Application
    Filed: March 24, 2005
    Publication date: September 28, 2006
    Inventors: Fernando Couto, Kristin Hendricks, Stacey Wallace
  • Publication number: 20050033031
    Abstract: The invention provides a method for humanizing a rabbit monoclonal antibody. In general, the method involves comparing an amino acid sequences of a parent rabbit antibody to the amino acid sequences of a similar human antibody, and altering the amino acid sequence of the parent rabbit antibody such its framework regions are more similar in sequence to the equivalent framework regions of the similar human antibody. In many embodiments, amino acids in the parent rabbit antibody that are not CDR contact residues, interchain contact residues, or buried residues, are not modified. The invention further provides nucleic acids encoding the subject antibodies, as well as vectors and host cells comprising the nucleic acids and methods for producing a subject antibody. The subject antibodies, nucleic acid compositions and kits find use in a variety of applications, including diagnostics and therapeutic treatment and research of conditions and diseases.
    Type: Application
    Filed: August 7, 2003
    Publication date: February 10, 2005
    Inventor: Fernando Couto